RSV Vaccination for Adults: A Guide to Respiratory Syncytial Virus (RSV)
What is RSV?
Respiratory Syncytial Virus (RSV) is a virus that primarily affects the upper respiratory system, causing symptoms like a runny nose, cough, and cold. In severe cases, it can lead to lung infections or pneumonia, particularly in vulnerable populations.
How Serious is RSV Illness?
RSV can be especially dangerous for certain adults. In the United States, it’s estimated that between 60,000 to 160,000 adults are hospitalized annually due to RSV, and approximately 6,000 to 10,000 adults die each year from the infection.
When to Seek Medical Attention?
Contact your healthcare provider if you experience any of the following:
- Difficulty breathing
- Inability to drink enough fluids
- Worsening symptoms
- Any other concerns
Who Needs to Be Vaccinated?
- All adults aged 75 and older.
- Adults aged 60-74 who are at increased risk of severe RSV disease.
What are the Risk Factors?
- Cardiovascular diseases such as heart failure and coronary artery disease.
- Lung diseases.
- End-stage renal disease.
- Diabetes mellitus.
- Severe obesity.
- Liver disorders.
- Neurologic or neuromuscular conditions.
- Hematologic disorders.
- Moderate or severe immune compromise.
- Frail individuals.
- Residents of nursing homes or long-term care facilities.
- Other chronic medical conditions or risk factors identified by healthcare providers.
When to Get Vaccinated?
The CDC recommends receiving the RSV vaccine in late summer or early fall for maximum benefit. The RSV vaccine is currently a one-time vaccination, not an annual one.
Contraindications for RSV Vaccination
There are three available RSV vaccines, each with specific contraindications:
- GSK’s Arexvy: Avoid if there is a history of severe allergic reaction, such as anaphylaxis, to any component of the vaccine.
- Pfizer’s ABRYSVO: Avoid if there is a history of severe allergic reaction to any component of the vaccine.
- Moderna’s mRESVIA: Avoid if there is a history of severe allergic reaction to any component of the vaccine.
References:
Connecting the Dots: Protecting All Ages from RSV
RSV doesn’t just affect children; adults, especially those over 60 or with specific health conditions, are also at significant risk. Just as Nirsevimab (Beyfortus) is crucial for protecting infants and young children from RSV, vaccines for adults play a vital role in preventing severe illness and complications. Learn more about how to protect your children from RSV in our detailed guide on pediatric RSV prevention.
